ATAI
3 known investors
ATAI is developing rapid-acting, durable mental health treatments to address unmet needs in psychiatric conditions affecting over one billion people globally. The company combines drug development, healthcare, and commercialization expertise to create evidence-based therapies for large-scale patient impact.
Investors · 3
Frequently asked questions
- What does ATAI do?
- ATAI is developing rapid-acting, durable mental health treatments to address unmet needs in psychiatric conditions affecting over one billion people globally. The company combines drug development, healthcare, and commercialization expertise to create evidence-based therapies for large-scale patient impact.
- Who are ATAI's investors?
- ATAI's investors include atai Life Sciences, AtaiBeckley, Catalio Capital Management, LP.